IP Library › Granted Patent US 12,241,893
Granted Patent B2
US 12,241,893 · App. 18/674,179 · Granted Mar 4, 2025

Bead-based analysis of a sample

Inventor: Alan Marc Fine (Prospect, CA)
Assignee: Alentic Microscience Inc.
G01N33/54313G01N21/41G01N21/55G01N21/59G01N33/56983G01N2021/1772
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,241,893
App. No.
18/674,179
Granted
Mar 4, 2025
Kind
B2
Abstract

A method includes attaching two or more beads to each unit of one or more units of a chemical component in a sample, to form, for each unit of the chemical component, a multi-bead complex including two or more beads and the unit of the chemical component; placing the sample on a surface of an image sensor; at the image sensor, receiving light originating at a light source, the received light including light reflected by, refracted by, or transmitted through the beads of the multi-bead complexes; at the image sensor, capturing one or more images of the sample from the received light; and identifying, in at least one of the images of the sample, separate multi-bead complexes, the identifying of the separate multi-bead complexes including associating the two or more beads of each of the multi-bead complexes based on proximity to one another.

Claims (50)

1. An apparatus comprising:

an image sensor having

an array of light sensitive elements at a sensor surface, and

a first surface; and

one or more processors configured to:

cause the image sensor to capture one or more images of a sample disposed on the first surface, wherein the sample comprises a unit of a chemical component, the unit of the chemical component bound to a first attachment unit and a second attachment unit,

wherein the first attachment unit is attached to a bead, and

wherein the second attachment unit is

attached at a location on the first surface, or

attached at a location on a second surface, wherein, when the second attachment unit is attached at the location on the second surface, the second surface comprises an upper surface with respect to the first surface of the apparatus, the upper surface facing the first surface,

such that the bead is attached to the first surface or the second surface through the unit of the chemical component, and

wherein the array of light sensitive elements is disposed and structured to capture the one or more images based on light originating at a light source, reflected by, refracted by, or transmitted through the bead, and received at the array of light sensitive elements at the sensor surface, and wherein the array of light sensitive elements has a pixel spacing that is smaller than 5 μm,

receive, from the image sensor, data representative of the captured one or more images of the sample disposed on the first surface,

identify the bead in at least one image of the one or more images of the sample,

identify, in the at least one image of the one or more images of the sample, the location at which the second attachment unit is attached on the first surface or on the second surface based on the identification of the bead, and

bound to the chemical component which is bound to the first attachment unit attached to the bead, a presence or a level of the chemical component in the sample.

2. The apparatus of claim 1 , wherein the second attachment unit is attached to the first surface, and wherein the first surface comprises the sensor surface.

3. The apparatus of claim 1 , comprising the second surface,

wherein the second surface is a surface of a lid that defines a gap occupied by the sample, and

wherein the second attachment unit is attached to the second surface.

4. The apparatus of claim 3 , wherein the second surface is arranged to form a layer of the sample with a thickness in a range from 1 μm to 100 μm between the second surface and the sensor surface.

5. The apparatus of claim 1 , wherein the first attachment unit and the second attachment unit comprise antibodies.

6. The apparatus of claim 1 , wherein the first attachment unit and the second attachment unit comprise antigens from a pathogen, and wherein the unit of the chemical component comprises an antibody to the pathogen.

7. The apparatus of claim 6 , wherein the pathogen comprises a virus.

8. The apparatus of claim 1 , wherein the second attachment unit is printed on the first surface or the second surface.

9. The apparatus of claim 1 , wherein a plurality of attachment units, including the second attachment unit, are attached at respective locations on the first surface or the second surface, the respective locations forming an array.

10. The apparatus of claim 1 , wherein the sample comprises whole blood of a human or animal.

11. An apparatus comprising:

an image sensor having

an array of light sensitive elements at a sensor surface, and

a surface; and

one or more processors communicatively coupled to the image sensor, configured to:

cause the image sensor to use the array of light sensitive elements to capture one or more images of a sample disposed on the surface, wherein the sample comprises a plurality of multi-bead complexes, each multi-bead complex of the plurality of multi-bead complexes comprising two or more respective beads attached to a respective unit of a chemical component, and

wherein the array of light sensitive elements is disposed and structured to capture one or more images based on light originating at a light source and reflected by, refracted by, or transmitted through the two or more respective beads of each multi-bead complex and received at the array of light sensitive elements at the sensor surface, and wherein the array of light sensitive elements has a pixel spacing that is smaller than 5 μm,

receive, from the image sensor, data representative of the captured one or more images of the sample disposed on the surface,

measure, in at least one image of the one or more images of the sample, a proximity to one another of the two or more respective beads of at least two different multi-bead complexes of the plurality of multi-bead complexes, and

identify, in the at least one image, two or more separate multi-bead complexes based on the measured proximity to one another of the two or more respective beads of the at least two different multi-bead complexes.

12. The apparatus of claim 11 , wherein the one or more processors are configured to identify a presence or a level of the chemical component in the sample, based on the identification of the two or more separate multi-bead complexes.

13. The apparatus of claim 11 , wherein the one or more processors are configured to enumerate a number of the plurality of multi-bead complexes in the sample.

14. The apparatus of claim 11 , wherein the sample comprises attachment units, and wherein, for each multi-bead complex comprising two or more respective beads attached to the respective unit of the chemical component,

two or more respective attachment units are bound to the respective unit of the chemical component, and

each attachment unit of the two or more respective attachment units is bound to at least one bead of the two or more respective beads,

such that each multi-bead complex of the plurality of multi-bead complexes comprises the two or more respective beads, the two or more respective attachment units, and the respective unit of the chemical component.

15. The apparatus of claim 14 , wherein the two or more respective attachment units of each multi-bead complex of the plurality of multi-bead complexes comprise antibodies.

16. The apparatus of claim 14 , wherein the two or more respective attachment units of each multi-bead complex of the plurality of multi-bead complexes comprise antigens from a pathogen, and

wherein the respective unit of the chemical component of each multi-bead complex of the plurality of multi-bead complexes comprises an antibody to the pathogen.

17. The apparatus of claim 16 , wherein the pathogen comprises a virus.

18. The apparatus of claim 14 , wherein at least two attachment units of the two or more respective attachment units of each multi-bead complex of the plurality of multi-bead complexes are different from one another.

19. The apparatus of claim 14 , wherein the two or more respective attachment units of each multi-bead complex of the plurality of multi-bead complexes are configured to bind at different locations at the respective unit of the chemical component of the multi-bead complex.

20. The apparatus of claim 11 , wherein at least two beads of the two or more respective beads of a first multi-bead complex of the plurality of multi-bead complexes differ in at least one of appearance, reflective characteristics, refractive characteristics, or transmissive characteristics, for the light originating at the light source.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 2024
From: FINE, ALAN MARC
To: ALENTIC MICROSCIENCE INC.
Reel/Frame 067522/0860 →
Continuity (5)
Continuation 18200301 · May 22, 2023
Division 17674967 · Feb 18, 2022
Division 16845458 · Apr 10, 2020
Continuation In Part 16368707 · Mar 28, 2019
Related Publication 20240385184A1 · Nov 21, 2024
References Cited (83)
US 9041790B2 · Fine et al. · 2015 [cited by applicant]
US 9075225B2 · Fine et al. · 2015 [cited by applicant]
US 9518920B2 · Fine et al. · 2016 [cited by applicant]
US 9720217B2 · Fine et al. · 2017 [cited by applicant]
US 9910254B2 · Fine et al. · 2018 [cited by applicant]
US 9952417B2 · Fine · 2018 [cited by applicant]
US 9989750B2 · Fine et al. · 2018 [cited by applicant]
US 10107997B2 · Fine · 2018 [cited by applicant]
US 10114203B2 · Fine et al. · 2018 [cited by applicant]
US 10153317B1 · Fine · 2018 [cited by applicant]
US 10249669B1 · Fine · 2019 [cited by applicant]
US 10461112B1 · Fine · 2019 [cited by applicant]
US 10684278B1 · Fine · 2020 [cited by applicant]
US 10991744B2 · Fine · 2021 [cited by applicant]
US 11099181B2 · Fine · 2021 [cited by applicant]
US 11255850B2 · Fine · 2022 [cited by applicant]
US 11609233B2 · Fine · 2023 [cited by applicant]
US 11719700B2 · Fine · 2023 [cited by applicant]
US 12123868B2 · Fine · 2024 [cited by applicant]
US 20060216696A1 · Goguen · 2006 [cited by applicant]
US 20110065209A1 · Heil et al. · 2011 [cited by applicant]
US 20130157288A1 · Kilfeather et al. · 2013 [cited by applicant]
US 20140152801A1 · Fine et al. · 2014 [cited by applicant]
US 20160041200A1 · Fine et al. · 2016 [cited by applicant]
US 20160187235A1 · Fine et al. · 2016 [cited by applicant]
US 20170074870A1 · Konry et al. · 2017 [cited by applicant]
US 20170293133A1 · Fine et al. · 2017 [cited by applicant]
US 20180284416A1 · Fine et al. · 2018 [cited by applicant]
US 20190054466A1 · Gershtein · 2019 [cited by applicant]
US 20190056384A1 · Gershtein · 2019 [cited by applicant]
US 20190056385A1 · Gershtein · 2019 [cited by applicant]
US 20190162648A1 · Fine · 2019 [cited by applicant]
US 20200309772A1 · Fine et al. · 2020 [cited by applicant]
US 20200309777A1 · Fine et al. · 2020 [cited by applicant]
US 20210311037A1 · Fine · 2021 [cited by applicant]
US 20210311038A1 · Fine · 2021 [cited by applicant]
US 20220082557A1 · Fine · 2022 [cited by applicant]
US 20220274109A1 · Gershtein · 2022 [cited by applicant]
US 20220412968A1 · Fine · 2022 [cited by applicant]
US 20230164299A1 · Fine · 2023 [cited by applicant]
US 20230184778A1 · Fine · 2023 [cited by examiner]
US 20230288407A1 · Fine · 2023 [cited by applicant]
CN 1635988 · 2005 [cited by applicant]
CN 105143886 · 2015 [cited by applicant]
CN 113631912 · 2021 [cited by applicant]
JP 2002544488 · 2002 [cited by applicant]
TW I641371 · 2018 [cited by applicant]
TW I642780 · 2018 [cited by applicant]
WO WO2000068692 · 2000 [cited by applicant]
WO WO2011026030 · 2011 [cited by applicant]
WO WO2011102903 · 2011 [cited by applicant]
WO WO2012061778 · 2012 [cited by applicant]
WO WO2013057634 · 2013 [cited by applicant]
WO WO2020191480 · 2020 [cited by applicant]
WO WO2021203201 · 2021 [cited by applicant]
Appleblom et al., “Homogeneous TR-FRET High-Throughput Screening Assay for Calcium-Dependent Multimerization of Sorcin”, www.sbsonline.org, Society for Biomolecular Sciences, 2007, 7 pages. [cited by applicant]
Barua et al., “Challenges associated with Penetration of Nanoparticles Across Cell and Tissue Barriers: A Review of Current Status and Future Prospects”, Nano Today, Apr. 2014, 9(2):223-243. [cited by applicant]
Bidinosti et al., “Novel one step immunoassays to Quantify a-Synuclein: Applications for Biomarker Development and High-throughput Screening”, Journal of Biological Chemistry 287(40):33691-33705, Sep. 28, 2012, 16 pages. [cited by applicant]
Chang et al., “Novel Diagnostic and Predictive Biomarkers in Pancreatic Adenocarcinoma”, International Journal of Molecular Sciences, Mar. 2017, 14 pages. [cited by applicant]
Chavda et al., “A Bead Aggregation Assay for Detection of Low-Affinity Protein-Protein Interactions Reveals Interactions between N-Terminal Domains of Inositol 1,4,5-Trisphosphate Receptors”, PLOS/One, Mar. 2013, 7 page… [cited by applicant]
Extended European Search Report in European Appln. No. 20779367.0, dated May 2, 2022, 11 pages. [cited by applicant]
Extended European Search Report in European Appln. No. 21784000.8, dated Aug. 28, 2023, 8 pages. [cited by applicant]
Hashizume et al., “Openings Between Defective Endothelial Cells Explain Tumor Vessel Leakiness”, Am. J. Pathol., Apr. 2000, 156(4):1363-1380. [cited by applicant]
International Preliminary Report on Patentability in International Application No. PCT/CA2021/050466, mailed on Oct. 20, 2022, 8 pages. [cited by applicant]
International Search Report and Written Opinion in International Application No. PCT/CA2020/050286, dated Jun. 5, 2020, 9 pages. [cited by applicant]
Kattke et al., “FRET-based Quantum Dot Immunoassay for Rapid and Sensitive Detection of Aspergillus amstelodami” Sensors 2011, 15 pages. [cited by applicant]
Medintz et al., “Self assembled nanoscale biosensors based on quantum dot FRET donors”, Nature Materials, Oct. 2003, 10 pages. [cited by applicant]
Miller et al., “Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer”, Journal of Oncology, Dec. 2009, 8 pages. [cited by applicant]
Moon et al., “Lensless Imaging for Point of Care Testing,” Conf. Proc. IEEE Eng. Med. Biol. Soc., Sep. 2009, 6376-6379, 8 pages. [cited by applicant]
Notice of Allowance in Chinese Application No. 202180034404.0, dated May 20, 2024, 6 pages (with English Translation). [cited by applicant]
Notice of Allowance in Japanese Application No. 2021557416, dated Feb. 6, 2024, 6 pages (with English Translation). [cited by applicant]
Office Action in Chinese Patent Application No. 202180034404.0, dated Dec. 28, 2023, 13 pages (with English Translation). [cited by applicant]
PCT International Preliminary Report on Patentability in International Appln. No. PCT/CA2020/050286, dated Oct. 7, 2021, 6 pages. [cited by applicant]
PCT International Search Report and Written Opinion in International Appln. No. PCT/CA2021/050466, dated Jul. 27, 2021, 10 pages. [cited by applicant]
Shao et al., “Diagnostic Technologies for Circulating Tumour Cells and Exosomes”, Bioscience Reports, Feb. 2016, 36(1):E00292. [cited by applicant]
Shi et al., “Nanoparticles based fluorescence energy transfer (FRET) for biosensing applications”, Journal of Materials Chemistry B, Royal Society of Chemistry, 2015, 17 pages. [cited by applicant]
Tagit et al., “Fluorescence Sensing of Circulating Diagnostic Biomarkers Using Molecular Probes and Nanoparticles”, ACS Sensors, Oct. 25, 2017, 16 pages. [cited by applicant]
Taiwanese Office Action in TW Appln. No. 109110649, dated Mar. 5, 2021, 19 pages with English translation. [cited by applicant]
Verma et al., “Covalent Immobilization of Doxorubicin in Glycine Functionalized Hydroxyapatite Nanoparticles for pH-Responsive Release”, New Journal of Chemistry, 2018, Abstract Only. [cited by applicant]
Wikipedia.org [online], “Immunoassay”, published on May 17, 2021, retrieved on Jun. 14, 2021, retrieved from URL<https://en.wikipedia.org/wiki/Immunoassay>, 7 pages. [cited by applicant]
Zeng et al., “Constructions of Silver Triangular Nanoplates-Quantum Dots FRET Systems”, Scientific Reports, www.nature.com/scientificreports, May 20, 2016, 8 pages. [cited by applicant]
Zorko et al., “Cell Penetrating Peptides: Mechanism and Kinetics of Cargo Delivery”, Adv. Drug Deliv. Rev. Mar. 2005, 57:529-545. [cited by applicant]
Communication pursuant to Article 94(3) EPC in European Application No. 20799367.0, mailed on Oct. 9, 2024, 14 pages. [cited by applicant]